InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Vaishnaw Akshay, Président, R&D. Officer active across 2 companies, notably ALNYLAM PHARMACEUTICALS, INC.. Aggregated, 6 disclosures have been logged. The latest transaction was disclosed on 21 December 2021 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
05,417 shares0
Common Stock
SEC:0001735276-21-000097·
05,417 shares0
Common Stock
SEC:0001735276-21-000097:0·
€581,45810,834 shares@ €53.66970.0015% mcap50.4% of flow
Common Stock
SEC:0001735276-21-000081·
€581,45810,834 shares@ €53.66970.0015% mcap25.2% of flow
Common Stock
SEC:0001735276-21-000081:0·
€572,91910,834 shares@ €52.88160.0015% mcap49.6% of flow
Common Stock
SEC:0001735276-21-000051·
€572,91910,834 shares@ €52.88160.0015% mcap24.8% of flow
Common Stock
SEC:0001735276-21-000051:0·
6 of 6 declarations
About Vaishnaw Akshay
Akshay Vaishnaw serves as President of Research and Development at Alnylam Pharmaceuticals, Inc. He is responsible for leading the company's research and development initiatives, ensuring innovation and advancement of projects. With a strong background in the pharmaceutical sector, he plays a key role in the strategy for developing new treatments. Akshay Vaishnaw is committed to supporting Alnylam's mission and promoting its success.
